Skip to main content
TempraMed Technologies logo

TempraMed Technologies — Investor Relations & Filings

Ticker · VIVI ISIN · CA88024B1022 LEI · 529900AK4AXUNXYDWH07 CSE Manufacturing
Filings indexed 93 across all filing types
Latest filing 2026-05-14 Capital/Financing Update
Country CA Canada
Listing CSE VIVI

About TempraMed Technologies

https://tempramed.com

TempraMed Technologies Ltd. develops and markets innovative, temperature-controlled storage solutions for injectable and temperature-sensitive pharmaceuticals, focusing on "last mile" control management for patients and healthcare providers. The company utilizes patented, space-grade insulation technology in its FDA-registered medical devices. Key products include the VIVI Cap, a thermal carrying case for insulin pens and weight loss medications, and the VIVI Epi, a temperature shield for epinephrine auto-injectors (EpiPen). These compact, maintenance-free solutions require no batteries or charging, ensuring medications remain within optimal temperature ranges 24/7/365, thereby safeguarding drug efficacy and minimizing the risk of spoilage due to temperature extremes.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 75% confidence The document is a corporate press release announcing two primary items: (1) the grant of an Indian design patent for the VIVI Cap Smart product and (2) the renewal of a royalty purchase agreement providing US$500,000 in financing for the company’s inventory build. While the patent grant itself does not fit into any of the specified financial report categories, the renewal of the RPA is clearly a financing arrangement—i.e., an update on the company’s fundraising/financing activity. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-05-14 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2026-04-30 English
Annual MD&A - English.pdf
Regulatory Filings
2026-04-30 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2026-04-30 English
Audited annual financial statements – English.pdf
Regulatory Filings
2026-04-30 English
Certificate and Articles of Incorporation.pdf
Regulatory Filings
2026-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.